ClinicalTrials.gg

Dengue clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 283 studies for Dengue across more than 10 countries. 44 are recruiting or about to start. 215 of them are mainly about Dengue (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Severe Dengue too: 290 studies, 47 open.

Status

Completed
176
Recruiting
27
Status unknown
26
Active, not recruiting
18
Not yet recruiting
14
Terminated
12

Phase

Phase 1
65
Phase 2
65
Phase 3
34
Early Phase 1
3
Phase 4
1

Where

United States
69
Thailand
30
Brazil
26
Colombia
21
Malaysia
20
Mexico
19

Who develops what

Add Dengue to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 4 programs from 4 companies, 4 with this as their studies’ main aim; 2 with a live phase 3 study; 2 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
Dengue VaccinesEarlier only
Evidence
  • NCT03342898 · Takeda · Phase 3 · background · “TDV” · registered Nov 2017
  • NCT02993757 · Sanofi · Phase 3 · background · “CYD Dengue Vaccine” · registered Dec 2016
  • NCT02992418 · Sanofi · Phase 3 · background · “CYD Dengue Vaccine” · registered Dec 2016
  • NCT02979535 · Sanofi · Phase 3 · background · “CYD Dengue Vaccine” · registered Nov 2016
  • NCT01943825 · Sanofi · Phase 2 · background · “CYD Dengue Vaccine” · registered Sep 2013
—00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 4 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (2)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Jan 2027 est.CP-COV03 · Hyundai Bioscience Co., Ltd. · Phase 3 main aimNCT07576868 A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2) — primary endpoint: [Part 1] Incidence and severity of Adverse Events (AEs) and Serious Adverse Events (SAEs) · 210 enrolled
  • 14 Apr 2027 est.TAK-003 · Takeda · Phase 3 main aimNCT06579755 A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) — primary endpoint: Number of Participants with Solicited Local (Injection Site) Adverse Events (AEs) Within 7 Days Post Vaccination at Day 1 · 800 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Dengue studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

16studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 27 Dengue studies recruiting now, 16 (59%) set no upper age limit and 11 (41%) stop at 75 or younger. 16 (59%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (33%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
1015 (56%)15 (56%)
1823 (85%)23 (85%)
3023 (85%)23 (85%)
4023 (85%)23 (85%)
5023 (85%)23 (85%)
6521 (78%)21 (78%)
7517 (63%)17 (63%)
8516 (59%)16 (59%)

Across all 283 studies, recruiting or not: 65% stop at 75 or younger and 62% at 65; 47% take children; 2% are for women only and 1% for men only; 67% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dengue studies take

Of 31 phase 2 interventional studies under Dengue, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo8–18 · 22 studies——
Phase 220 mo14–38 · 31 studies21 mo14–47 · 21 studies—
Phase 324 mo7–30 · 21 studies——
Interventional, no phase12 mo6–36 · 30 studies—12 mo5–27 · 25 studies
Observational47 mo31–71 · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 283. Browse all 283 → or search them.